A Glimpse Of Hope Amid Trump Tariff Setback In a landmark decision, a US federal appeals court voted 7–4 to strike down most of President Trump’s global tariffs imposed under the International Emergency Economic Powers Act (IEEPA), ruling that the administration lacked explicit congressional authority. The verdict delivers a heavy blow to the cornerstone of Trump’s trade policy and marks its second consecutive defeat in the closely watched case of V.O.S. Selections vs Trump. Trump blasted the ru...
2Q25: Weakness Persists On Multiple Headwinds; Better 2H25 Ahead Kossan reported softer earnings in 2Q25, dragged by declining volume sales and temporary plant closure due to Putra Heights’ explosion incident in April. Positively, better operating efficiency, lower input cost and strong interest income partially offset these weaknesses. Moving forward, we anticipate a positive backdrop from the US’ reinitiated replenishment activities. Kossan’s strong balance sheet also remains as a key re-ratin...
GREATER CHINA Results CSPC Pharmaceutical Group (1093 HK/BUY/HK$10.51/Target: HK$12.00) 1H25: Results miss; expects hoh sales recovery and two more BD deals in 2H25. Ganfeng Lithium (1772 HK/BUY/HK$30.80/Target: HK$40.00) 2Q25: Net loss in line; 3Q25 turnaround on the back of lithium carbonate price recovery. Maintain BUY, target price: HK$40.00. Li Ning (2331 HK/HOLD/HK$19.70/Target: HK$18.90) 1H25: Results beat but challenges remain in 2H25; fa...
2Q25 Results Preview: Forecasting Sequential Weakness We foresee sequentially weaker 2Q25 results for Kossan, potentially due to lower volume sales, softening non-US market and impacts from Putra Heights’ gas explosion incident. The group may deliver a visible earnings recovery only in 2H25 as US customers’ frontloaded inventories are depleted. Meanwhile, the group’s shifting focus to specialty gloves and automation initiatives will enhance efficiency and mid-to-long term profitability. Maintain...
GREATER CHINA Results China Resources Beer (291 HK/BUY/HK$28.28/Target: HK$33.80): 1H25: Results beat; Heineken and sub-premium the core for next stage. Guangzhou Tinci Materials Technology (002709 CH/BUY/Rmb20.60/Target: Rmb30.00): 2Q25: Earnings miss on ASP and margins; Maintain BUY. Cut target price from Rmb39.60 to Rmb30.0. Xiaomi Corp (1810 HK/BUY/HK$52.40/Target: HK$69.20): 2Q25: Record-high bottom line; EV business to be boosted by YU7 deliveries. Maintain BUY. XPeng Inc (9868 HK/BUY/HK$7...
A director at Kossan Rubber Industries Berhad bought 1,000,000 shares at 1.190MYR and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
Levelling The Field: Tariff Normalisation Reinforces Malaysia’s Role As An Onshoring Destination At last, the White House administration has updated the reciprocal tariff schedule established under the earlier 2025 trade policy, based on fresh assessments and evolving negotiations with trading partners. Accordingly, the modifications reflect outcomes of bilateral talks and align tariff changes with ongoing partnerships to address perceived imbalances and encourage investments and trade reforms. ...
Mounting Pressures From Elevated US Tariffs And China Competition The Malaysian glove sector is weathering challenges such as the geopolitical reshuffling, higher US reciprocal tariffs (25%), and intensifying competition from China. Earnings delivery is lagging expectations with a meaningful recovery expected only in 4Q25. Although the sector’s forward valuations are well below the historical average, we acknowledge that there could be a potential long-term structural de-rating. We lower our 202...
GREATER CHINA Sector Healthcare Bi-Weekly: Expecting strong 1H25 results. Maintain OVERWEIGHT. Results Contemporary Amperex Technology (300750 CH/BUY/Rmb277.09 /Target: Rmb390.00) 2Q25: Earnings in line, with margins hitting record-high levels. Maintain A-share at BUY. Downgrade H-share to HOLD. New Oriental Education & Technology Group (EDU US/BUY/US$44.37/Target: US$55.00) ...
Cyclical Volatility From Episodic Narratives Amid geopolitical reshuffling, the US’ reciprocal tariffs, and intensifying China competitions, the Malaysian glove sector rode through a volatile 1H25. Despite the ytd steep share price correction reflecting mixed investor sentiments, we opine that riskreward remains attractive given the sector’s bargain forward valuations (-2SD below mean). 2H25 earnings will also see sequential improvement on better US replenishments. Maintain OVERWEIGHT.
Recalibrating New Strategies: Product Differentiation And Automation Despite a challenging 1H25 due to US customers’ frontloaded inventories and stiffer competition from China glovemakers, Kossan is well-positioned to deliver visible earnings recovery in 2H25. Meanwhile, the group’s shifting focus into specialty gloves and automation initiatives to enhance efficiency are expected to improve mid/long-term profitability. Overall, Kossan offers good trading opportunities given its palatable valuati...
GREATER CHINA Sector Industrial Automation: Development of humanoid robots continues to accelerate, but broader market lukewarm. Internet: JD’s new initiative in on-demand delivery is reshaping FD market dynamics. INDONESIA Update Bank Syariah Indonesia (BRIS IJ/BUY/Rp2,620/Target: Rp3,450): Danantara plans to acquire BRIS. MALAYSIA Results VS Industry (VSI MK/BUY/RM0.775/Target: RM0.92): 3QFY25: Within house but below consensus expectations; expect a stronger 4QFY25. Update Kossan Rubber (KRI...
1Q25: Soft Start But Core Profitability Improves Kossan reported a softer revenue in 1Q25 but core earnings improved. The earnings strength stemmed from a sustainable ASP uptrend and lower input costs which offset declining volume sales. For the rest of 2025, we expect a positive backdrop from escalating US-China trade tensions which should lift the sales volume and earnings trend. Kossan’s strong balance sheet and potentially better capital management are also key re-rating catalysts. Maintain ...
Opportunities In A Ringgit Resurgence Environment The sharp ringgit appreciation driven by de-dollarisation and thus a broader reallocation of capital toward emerging market currencies support our view of a moderate upside for Malaysian equities. Key beneficiaries include importers and companies with high US dollar debt, while exporters may face margin pressure. While historical parallel suggests temporary trading opportunities, we recommend a tactical trading stance, focusing on value-driven op...
A Kaleidoscope Of Perceptions Underneath the facade of geopolitical reshuffling and the US’ reciprocal tariffs, the Malaysian glove sector faces mixed investor sentiments as uncertainty builds up. Nevertheless, the sector’s core fundamentals remain solid as we anticipate sequential earnings growth driven by a full recapturing of US market share. More importantly, ytd retracement and bargain forward valuations are offering an attractive risk-reward balance. Maintain OVERWEIGHT.
GREATER CHINA Sector Banking Playing safe amid tariff fears. Small/Mid Cap Highlights JBM Healthcare (2161 HK/BUY/HK$1.75/Target: HK$2.42) FY26: New rounds of marketing campaigns to fuel growth. INDONESIA Results Merdeka Copper Gold (MDKA IJ/BUY/Rp1,040/Target: Rp1,900) FY24: Below our and street’s expectations MALAYSIA Sector Gloves ...
Seasons Of Fall In the last two months, the Malaysian gloves sector faced an unprecedented selldown due to a slower-than-expected recovery outlook on intensifying competition in non-US markets and US distributors’ frontloaded inventories. This was also accelerated by US’ volatile trade policies, causing investors to turn risk-off. Nevertheless, the sector is still on track for sequential earnings growth, with bargain valuations offering attractive riskreward balance. Upgrade to OVERWEIGHT.
GREATER CHINA Sector Property Shenzhen and Guangzhou seeing notable improvement in demand-supply dynamics. Results ECARX Holdings Inc (ECX US/BUY/US$2.67/Target: US$3.40) 4Q24: Net loss narrows due to revenue growth. Maintain BUY. Target price: US$3.40. INDONESIA Update XL Axiata (EXCL IJ/BUY/Rp2,260/Target: Rp3,300) XLSmart estimates potential cost synergies of US$300-...
GREATER CHINA Sector Automobile: Weekly: PV sales rebound wow but remain low due to wait-and-see sentiment. Maintain MARKET WEIGHT on the sector. Top BUYs: Geely, CATL, Fuyao and Desay. Renewable Energy: Solar energy equipment: Policy-driven installation rush to support prices; milder module shipment growth in 2025. Results Alibaba Group (9988 HK/BUY/HK$120.90/Target: HK$150.00): 3QFY25: CMR beat; all-in AI; capex in next three years to exceed that of the past decade. Lenovo Group (992 HK/BUY/HK...
4Q24: Misses Expectations But Delivers Steady Profitability Kossan reported commendable 4Q24 core numbers. The earnings strength mainly stemmed from higher volume sales, a sustainable ASP uptrend, and a positive backdrop from escalating US-China trade tensions. Nevertheless, forex headwinds and higher operating costs dampened gloves margins in 4Q24. Moving into 2025, we assess potential earnings softening in 1Q25, but remain positive on the full-year outlook and better capital management. Upgrad...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.